Harnessing nitric oxide for preventing, limiting and treating the severe pulmonary consequences of COVID-19

The ongoing outbreak of COVID-19 has quickly become a daunting challenge to global health. In the absence of targeted therapy and a reported 5.5% case fatality rate in the United States, treatments preventing rapid cardiopulmonary failure are urgently needed. Clinical features, pathology and homolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Adusumilli, Nagasai C., Zhang, David, Friedman, Joel M., Friedman, Adam J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362842/
https://www.ncbi.nlm.nih.gov/pubmed/32681986
http://dx.doi.org/10.1016/j.niox.2020.07.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362842/
https://www.ncbi.nlm.nih.gov/pubmed/32681986
http://dx.doi.org/10.1016/j.niox.2020.07.003

Ejemplares similares